The lab focuses on understanding how RNA editing impacts the immune system, specifically in regulating the body's response to infections while avoiding attacks on its own cells. By studying an enzyme called ADAR1, the lab aims to uncover how this enzyme edits RNA to prevent autoimmune diseases and enhance our understanding of related inflammatory conditions. This work combines genetic screening and biochemical methods to identify how specific RNA molecules are processed within cells, paving the way for new therapeutic approaches.

Dr. Bingwei Lu's lab at Stanford University explores the connections between tau protein abnormalities and mitochondrial dysfunction in neurodegenerative diseases like Alzheimer's and Parkinson's. By understanding how these factors interact, the lab aims to develop new therapeutic strategies to combat a variety of brain disorders. The research combines molecular genetics, biochemistry, and cell biology techniques to uncover the mechanisms underlying these diseases.

Dr. Stephen Joseph Galli's lab at Stanford University studies how genetic variations affect the immune responses of mast cells to honeybee venom. They aim to uncover how these immune responses can be both harmful, leading to allergic reactions, or beneficial, potentially offering protection against venom toxicity. Their research involves using genetically diverse mice to explore these pathways and identify ways to improve treatment for venom allergies and related disorders.

Dr. Jennifer A McNab's lab focuses on improving the treatment options for patients with epilepsy, especially those who do not show visible brain lesions using traditional imaging methods. By developing advanced diffusion MRI techniques, the lab aims to accurately locate the areas in the brain where seizures originate, helping neurosurgeons target these areas more effectively. The research could significantly enhance the chances of successful surgery for epilepsy patients, leading to better outcomes and potentially curative treatments.

Jonathan Z Long's lab at Stanford University focuses on understanding how different types of metabolites, particularly ketone bodies and lactate, influence energy balance and metabolism in the body. They investigate specific biochemical pathways and how metabolic tissues communicate to maintain healthy function. The research aims to identify novel treatments for obesity and metabolic disorders by studying these metabolic signals and their interactions.

Dr. Michael Fischbach's lab at Stanford University focuses on harnessing the power of the human microbiome to create innovative vaccines. By engineering certain beneficial bacteria to target diseases like cancer and autoimmune conditions, the lab aims to develop solutions that are effective, durable, and easy to distribute, particularly in low-resource settings. This research combines cutting-edge technologies from immunology and microbiology to redefine how vaccines can be designed and applied.

Dr. Polly Morrell Fordyce's lab focuses on developing innovative microfluidic technologies to enhance personalized anti-cancer immunotherapies. By studying the interactions between T cell receptors and antigen-presenting molecules, the lab aims to identify which combinations can effectively activate T cells to combat cancer cells. This research seeks to improve the prediction of T cell responses, paving the way for safer and more effective immunotherapies.

Dr. Alia Crum's research lab focuses on improving the overall health of cancer patients by developing innovative mental health interventions. They are testing a smartphone-based program called MINDSET, which aims to shift patients' mindsets at the time of their cancer diagnosis. By addressing both mental and physical symptoms, their work seeks to improve the quality of life for people undergoing cancer treatment, ultimately leading to better clinical outcomes.

Dr. Paul S. Mischel's lab at Stanford University focuses on developing new treatments for glioblastoma, a highly aggressive brain cancer. The research aims to discover the proteins that glioblastoma cells depend on for survival, particularly when they have a mutated form of the epidermal growth factor receptor (EGFR). By using advanced chemical and proteomic techniques, the lab seeks to identify drug targets that can lead to more effective therapies for this challenging disease.

William Moerner's lab at Stanford focuses on developing advanced imaging techniques to study cells at the nanoscale. By using super-resolution microscopy and single-molecule tracking, the lab aims to visualize the dynamic behaviors of essential biomolecules like proteins and RNA in their natural environments. This research has important implications for understanding cellular processes in both healthy and diseased states.

Dr. Elizabeth Mormino's lab at Stanford University investigates how memory decline occurs in aging and early Alzheimer's disease. They focus on understanding how changes in the brain's structure and function, specifically in the hippocampus, relate to memory loss. By using cutting-edge imaging techniques and biofluid analysis, her team aims to develop models that predict individual memory decline, helping to identify early pathways of Alzheimer's before major symptoms develop.

Dr. Karl Deisseroth's lab at Stanford University focuses on understanding how brain states influence neural activity and behavior. By developing advanced imaging and computational techniques, the lab seeks to reveal how different types of neurons interact during various brain states and how these interactions affect sensory perception and behavior. This work is essential for shedding light on the mechanisms behind mental processes and could lead to improved treatments for neurological and psychiatric disorders.

Dr. Aaron D. Gitler's lab at Stanford University focuses on understanding the biological mechanisms behind neurodegenerative diseases like ALS and Parkinson's disease. By using yeast and human genetics, the lab aims to uncover novel genetic risk factors and therapeutic strategies, including targeting specific proteins and RNA splicing events. Their work involves innovative technologies such as CRISPR and RNA sequencing to explore pathways that lead to these devastating conditions and to identify potential treatments.

Dr. Michelle Monje-Deisseroth's lab at Stanford University focuses on understanding how neurons contribute to the growth and formation of low-grade gliomas, a common type of brain tumor, particularly in children with Neurofibromatosis type 1 (NF1). Their research aims to explore the interactions between nerve cells and tumor cells to enhance treatment options and reduce long-term side effects in young patients. The lab employs various techniques to study the biological mechanisms behind these tumors and how they can be targeted for better therapies.

Dr. Lauren O'Connell's lab studies how young animals learn to communicate and interact with others through movement, a process known as perceptual motor development. Using social tadpoles, her research explores how dopamine signaling and a specific protein related to Fragile X syndrome affect this development. By understanding these brain mechanisms, the lab aims to uncover insights that could help in addressing communication and developmental issues, particularly in conditions like autism.

Dr. Huttenhain's lab studies the mu-opioid receptor (MOR), a key player in pain relief and addiction. By investigating how MOR interacts with different signaling pathways and its location within cells, they aim to discover safer pain management strategies with fewer side effects. Using advanced techniques such as proteomics and CRISPR, the lab seeks to identify new molecular targets that could lead to better treatments for pain and opioid addiction.

Dr. Feliks Kogan's research lab at Stanford University focuses on innovative imaging techniques for studying osteoarthritis (OA), a condition impacting millions by causing pain and disability. The lab aims to develop new non-invasive MRI methods to assess inflammation in joints without needing contrast agents, helping to understand and monitor the disease better. They also explore how physiological stress affects joint response and metabolism, particularly across different ages and sexes, to improve early detection and treatment strategies for OA.

Dr. Seung K. Kim's lab focuses on understanding pancreatic cancer and its relationships with diabetes. They investigate how certain cells in the pancreas undergo changes that could lead to cancer, particularly pancreatic ductal adenocarcinoma (PDAC). The lab studies interactions between immune cells and cancer cells to determine how these relationships influence disease development. They aim to uncover the genetic and signaling pathways involved in these processes to help improve treatment options and early diagnosis.

Dr. Dmitri Petrov's research lab at Stanford University focuses on understanding how organisms adapt rapidly to changing environments. By studying various experimental systems, such as yeast and fruit flies, along with cancer models in mice, the lab aims to build a comprehensive theory of adaptation that accounts for both short-term evolution and patterns seen in long-term genomic data.

In Jeffrey D. Axelrod's lab at Stanford University, researchers focus on understanding planar cell polarity (PCP) signaling, a critical process that ensures cells are correctly oriented and positioned within tissues. This signaling pathway is important for proper heart development and can lead to congenital heart defects when disrupted. The lab employs the fruit fly Drosophila as a model organism, using advanced genetic, imaging, and biochemical techniques to uncover the mechanisms behind PCP signaling. Their work not only advances basic biology but also aims to inform potential treatments for related diseases.